0 results for 'Sanofi US Services Inc'
Supreme Court Brief: Fact-Dependent IP Hearing | ADA 'Tester' Case
IP lawyers were less than thrilled by Monday's U.S. Supreme Court hearing of a case involving complex issues of patent law in the biotech space.Supreme Court Brief: Who's at the Lectern | Oral Argument Previews
The justices are set to hear a dispute over cholesterol medication patents alleging that recent changes to patent law have created an undue disclosure burden on creators.
Why the Supreme Court Should Reject Attempts to Monopolize a Therapeutic Target
Patents that lay claim to all antibody therapeutics for a biological target stifle medical innovation and hurt patients.
Deal Watch: Cleary Leads Big Week in Deals as Bank Crises Bring More Work to Law Firms
Deal activity is strong for the second straight week, while a host of law firms landed on several big bank collapse deals.Litigators of the Week Runners-Up and Shout Outs
Wins by litigators at Gibson Dunn, Hogan Lovells, Kirkland & Ellis, and Morgan Lewis lead this week's line-up.
Law Journal Press | Digital Book
Anatomy of a Merger: Strategies and Techniques for Negotiating Corporate Acquisitions
Authors: James C. Freund
View this Book
View more book results for the query "Sanofi US Services Inc"
Eli Lilly's Insulin Price Cut Not Likely to Extricate It From Legal Morass
"If a company has acquired or maintained monopoly power through anticompetitive means, they're liable under the antitrust laws whether or not they're exploiting their monopoly power by charging monopoly prices," said Daniel Crane, a professor at the University of Michigan Law School.
3rd Circuit Sides With Drug Manufacturers in 340B Contract Pharmacy Case
"Legal duties do not spring from silence. Congress never said that drug makers must deliver discounted Section 340B drugs to an unlimited number of contract pharmacies," Judge Stephanos Bibas wrote. "So by trying to enforce that supposed requirement, the government overstepped the statute's bounds. And HHS did not violate the APA by purporting to withdraw the proposed ADR Rule before later finalizing it."
In 340B Contract Pharmacy Case 3rd Circuit Sides With Drug Manufacturers
"Legal duties do not spring from silence. Congress never said that drug makers must deliver discounted Section 340B drugs to an unlimited number of contract pharmacies," Judge Stephanos Bibas wrote. "So by trying to enforce that supposed requirement, the government overstepped the statute's bounds. And HHS did not violate the APA by purporting to withdraw the proposed ADR Rule before later finalizing it."
Scientific Lab Behind Dozens of Product Recalls Under the Microscope
In lawsuits, GlaxoSmithKline, Unilever and others are challenging the scientific methods used by Valisure, the Connecticut laboratory whose reports have prompted recalls, and subsequent class actions, over drugs, sunscreen and dry shampoo.
Supreme Court To Revisit the Patent Enablement Standard
The decision in 'Amgen v. Sanofi' has the potential to have a significant impact on inventors and patent drafters, and the breadth with which they may be able to claim their inventions.TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Andy Goldberg, Laner Muchin Managing Partner 1 minute read
- Legal Speak at Legalweek 2024: Priori CEO and Co-Founder Basha Rubin; Shook, Hardy & Bacon Partner Patrick Oot 1 minute read